细胞动力学蛋白调节器1:一个潜在的致癌驱动因素
Sijing Li1,2,3, Omar Motiño1,2, Flavia Lambertucci1,2
1Centre de Recherche des Cordeliers, Université Paris Cité, Sorbonne Université, Equipe labellisée par la Ligue contre le cancer, Inserm U1138, Paris, France.
Molecular cancer
|August 10, 2023
概括
细胞动力学1 (PRC1) 的蛋白调节器在28种癌症类型中过度表达,与预后不佳和癌症相关途径的改变相关. 准PRC1可能为各种癌症提供新的治疗策略.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 癌症基因组学 癌症基因组学
背景情况:
- 细胞动化1 (PRC1) 的蛋白调节器在细胞分裂中起作用.
- 新出现的证据将PRC1与各种人类癌症联系起来.
研究的目的:
- 研究PRC1在28种癌症类型中的表达,预后价值和分子机制.
- 探索PRC1与免疫检查点和患者结果的关联.
主要方法:
- 分析了28种癌症类型中的瘤与非恶性组织中的PRC1表达.
- 基于PRC1表达和甲基化的预测值评估.
- 与PRC1水平相关的差异表达基因 (DEGs) 的识别和途径分析.
- 与免疫检查点基因和T细胞透的相关性分析.
主要成果:
- 在28种癌症类型的瘤组织中,PRC1的高调显著.
- 高PRC1表达与多种癌症 (如ACC,LUAD,PAAD) 的不良预后相关.
- 与PRC1相关的DEG在细胞周期,DNA修复,EMT和细胞迁移途径中得到丰富.
- PRC1表达与免疫检查点基因 (例如PDCD1,CTLA4) 和TH2细胞具有正相关性.
结论:
- 过度表达PRC1是预后不佳的显著泛癌指标.
- PRC1影响关键的致癌途径和瘤微环境.
- 在瘤学中,PRC1是潜在的诊断和治疗点.
更多相关视频
相关概念视频
Positive Regulator Molecules
5.5K
Mitotic cell division results in daughter cells that exactly resemble the parent cell. However, errors in the DNA replication or distribution of genetic material may lead to genetic mutations that may be passed down to every new cell formed from the resulting abnormal cell. Propagation of such mutant cells is restricted through checkpoint mechanisms present at different stages of the cell cycle. These checkpoints involve regulator molecules that either promote or demote cell cycle events.
5.5K
Negative Regulator Molecules
35.4K
Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
35.4K
mTOR Signaling and Cancer Progression
3.8K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.8K
The Retinoblastoma Gene
4.1K
Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
4.1K
Abnormal Proliferation
4.6K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.6K
PI3K/mTOR/AKT Signaling Pathway
3.7K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
3.7K


